<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia</dc:title>
  <dc:creator>BUSHMAN, J. E</dc:creator>
  <dc:creator>PALMIERI, D</dc:creator>
  <dc:creator>WHINNA, H. C</dc:creator>
  <dc:creator>CHURCH, F. C</dc:creator>
  <dc:relation>Leukemia research -- Leuk. res, CODEN LEREDD, ISSN 0145-2126, Vol. 24 (7) , pp. 559-565</dc:relation>
  <dc:date>2000</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Article</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>Elsevier Science</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>37 ref</dc:format>
  <dc:subject xml:lang="fr">Appareil circulatoire pathologie</dc:subject>
  <dc:subject xml:lang="fr">Coagulopathie</dc:subject>
  <dc:subject xml:lang="fr">Enzyme</dc:subject>
  <dc:subject xml:lang="fr">Homme</dc:subject>
  <dc:subject xml:lang="fr">Hydrolases</dc:subject>
  <dc:subject xml:lang="fr">Hémopathie maligne</dc:subject>
  <dc:subject xml:lang="fr">Hémopathie</dc:subject>
  <dc:subject xml:lang="fr">Lymphoprolifératif syndrome</dc:subject>
  <dc:subject xml:lang="fr">Vaisseau sanguin pathologie</dc:subject>
  <dc:subject xml:lang="fr">Aigu</dc:subject>
  <dc:subject xml:lang="fr">Anticancéreux</dc:subject>
  <dc:subject xml:lang="fr">Anticoagulant</dc:subject>
  <dc:subject xml:lang="fr">Antithrombine III</dc:subject>
  <dc:subject xml:lang="fr">Asparaginase</dc:subject>
  <dc:subject xml:lang="fr">Biosynthèse</dc:subject>
  <dc:subject xml:lang="fr">Chimiothérapie</dc:subject>
  <dc:subject xml:lang="fr">Complication</dc:subject>
  <dc:subject xml:lang="fr">Déficit</dc:subject>
  <dc:subject xml:lang="fr">Enfant</dc:subject>
  <dc:subject xml:lang="fr">Foie</dc:subject>
  <dc:subject xml:lang="fr">Fonction hépatique</dc:subject>
  <dc:subject xml:lang="fr">Leucémie lymphoblastique</dc:subject>
  <dc:subject xml:lang="fr">Métabolisme</dc:subject>
  <dc:subject xml:lang="fr">Thrombose</dc:subject>
  <dc:subject xml:lang="fr">Toxicité</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="en">Cardiovascular disease</dc:subject>
  <dc:subject xml:lang="en">Coagulopathy</dc:subject>
  <dc:subject xml:lang="en">Enzyme</dc:subject>
  <dc:subject xml:lang="en">Human</dc:subject>
  <dc:subject xml:lang="en">Hydrolases</dc:subject>
  <dc:subject xml:lang="en">Malignant hemopathy</dc:subject>
  <dc:subject xml:lang="en">Hemopathy</dc:subject>
  <dc:subject xml:lang="en">Lymphoproliferative syndrome</dc:subject>
  <dc:subject xml:lang="en">Vascular disease</dc:subject>
  <dc:subject xml:lang="en">Acute</dc:subject>
  <dc:subject xml:lang="en">Antineoplastic agent</dc:subject>
  <dc:subject xml:lang="en">Anticoagulant</dc:subject>
  <dc:subject xml:lang="en">Antithrombin III</dc:subject>
  <dc:subject xml:lang="en">Asparaginase</dc:subject>
  <dc:subject xml:lang="en">Biosynthesis</dc:subject>
  <dc:subject xml:lang="en">Chemotherapy</dc:subject>
  <dc:subject xml:lang="en">Complication</dc:subject>
  <dc:subject xml:lang="en">Deficiency</dc:subject>
  <dc:subject xml:lang="en">Child</dc:subject>
  <dc:subject xml:lang="en">Liver</dc:subject>
  <dc:subject xml:lang="en">Liver function</dc:subject>
  <dc:subject xml:lang="en">Acute lymphocytic leukemia</dc:subject>
  <dc:subject xml:lang="en">Metabolism</dc:subject>
  <dc:subject xml:lang="en">Thrombosis</dc:subject>
  <dc:subject xml:lang="en">Toxicity</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="es">Aparato circulatorio patología</dc:subject>
  <dc:subject xml:lang="es">Coagulopatía</dc:subject>
  <dc:subject xml:lang="es">Enzima</dc:subject>
  <dc:subject xml:lang="es">Hombre</dc:subject>
  <dc:subject xml:lang="es">Hydrolases</dc:subject>
  <dc:subject xml:lang="es">Hemopatía maligna</dc:subject>
  <dc:subject xml:lang="es">Hemopatía</dc:subject>
  <dc:subject xml:lang="es">Linfoproliferativo síndrome</dc:subject>
  <dc:subject xml:lang="es">Vaso sanguíneo patología</dc:subject>
  <dc:subject xml:lang="es">Agudo</dc:subject>
  <dc:subject xml:lang="es">Anticanceroso</dc:subject>
  <dc:subject xml:lang="es">Anticoagulante</dc:subject>
  <dc:subject xml:lang="es">Antitrombina III</dc:subject>
  <dc:subject xml:lang="es">Asparaginase</dc:subject>
  <dc:subject xml:lang="es">Biosíntesis</dc:subject>
  <dc:subject xml:lang="es">Quimioterapia</dc:subject>
  <dc:subject xml:lang="es">Complicación</dc:subject>
  <dc:subject xml:lang="es">Déficiencia</dc:subject>
  <dc:subject xml:lang="es">Niño</dc:subject>
  <dc:subject xml:lang="es">Hígado</dc:subject>
  <dc:subject xml:lang="es">Función hepática</dc:subject>
  <dc:subject xml:lang="es">Leucemia linfoblástica</dc:subject>
  <dc:subject xml:lang="es">Metabolismo</dc:subject>
  <dc:subject xml:lang="es">Trombosis</dc:subject>
  <dc:subject xml:lang="es">Toxicidad</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject>002B02U04: Toxicité: appareil digestif / Toxicity: digestive system</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 1446449</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>